FDA Determines Regulatory Review Period for PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM

Summary

The U.S. Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM, a medical device, in accordance with federal regulations, following a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).